3. - Universitätsklinik für FRAUENHEILKUNDE Innsbruck

7.
106
12. Mueller-Holzner, E.; Frede, T.; Daniaux, M.; Ban, M.; Taucher, S.; Schneitter,
A.; Zeimet, AG.; Marth, C.:
Ultrasound-guided core needle biopsy of the breast: Does frozen section
give an accurate diagnosis?
BREAST CANCER RESEARCH AND TREATMENT. 2007; 106(3); 399-406.
13. Ott, HW.; Mattle, V.; Hadziomerovic, D.; Licht, P.; Doinghaus, K.; Rubbert,
A.; Manger, K.; Manger, B.; Kalden, J.; Wildt, L.:
Treatment of hereditary angioneurotic oedema (HANE) with tibolone.
CLINICAL ENDOCRINOLOGY. 2007; 66(2); 180-184.
14. Polterauer, S.; Grimm, C.; Mustea, A.; Concin, N.; Tanner, B.; Thiel, F.; Heinze,
G.; Reinthaller, A.; Zeillinger, R.; Hefler, LA.:
Vascular endothelial growth factor gene polymorphisms in ovarian cancer.
GYNECOLOGIC ONCOLOGY. 2007; 105(2); 385-389.
15. Reimer, D.; Sadr, S.; Wiedemair, A.; Stadlmann, S.; Concin, N.; Hofstetter, G.;
Muller-Holzner, E.; Marth, C.; Zeimet, AG.:
Clinical relevance of E2F family members in ovarian cancer - An evaluation
in a training set of 77 patients.
CLINICAL CANCER RESEARCH. 2007; 13(1); 144-151.
16. Reimer, D.; Steppan, I.; Wiedemair, A.; Concin, N.; Hofstetter, G.; Marth, C.;
Muller-Holzner, E.; Zeimet, AG.:
Soluble isoforms but not the transmembrane form of coxsackie-adenovirus
receptor are of clinical relevance in epithelial ovarian cancer.
INTERNATIONAL JOURNAL OF CANCER. 2007; 120(12); 2568-2575.
17. Ressler, S.; Scheiden, R.; Dreier, K.; Laich, A.; Muller-Holzner, E.; Pircher, H.;
Morandell, D.; Stein, I.; Viertler, HP.; Santer, FR.; Widschwendter, A.; Even,
J.; Jansen-Durr, P.; Capesius, C.; Zwerschke, W.:
High-risk human papillomavirus E7 oncoprotein detection in cervical squamous
cell carcinoma.
CLINICAL CANCER RESEARCH. 2007; 13(23); 7067-7072.
18. Salani, R.; Davidson, B.; Fiegl, M.; Marth, C.; Muller-Holzner, E.; Gastl, G.;
Huang, HY.; Hsiao, JC.; Lin, HS.; Wang, TL.; Lin, BL.; Shih, LM.:
Measurement of cyclin E genomic copy number and strand length